What is the treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

Topical antibiotics are the first-line treatment for bacterial conjunctivitis, providing higher local concentration, fewer systemic side effects, and a shorter treatment duration of 5-7 days. 1

First-Line Treatment Options

The American Academy of Ophthalmology recommends a 5-7 day course of broad-spectrum topical antibiotics for mild bacterial conjunctivitis in adults 1. The WHO Expert Committee endorses the following options:

  • Topical gentamicin
  • Topical tetracycline
  • Topical ofloxacin 2

For standard dosing of fluoroquinolones (e.g., gatifloxacin):

  • Day 1: One drop every two hours while awake (up to 8 times)
  • Days 2-7: One drop 2-4 times daily while awake 3

Efficacy and Selection Considerations

  • Topical antibiotics provide earlier clinical and microbiological remission compared to placebo, particularly in days 2-5 of treatment 2, 1
  • No clinical evidence suggests superiority of any particular antibiotic for bacterial conjunctivitis, allowing selection of the most convenient or least expensive option 1
  • Bacterial resistance should be considered when selecting an antibiotic, as resistance to fluoroquinolones appears to be increasing, particularly with methicillin-resistant Staphylococcus aureus (MRSA) 2

Special Populations and Situations

Children

  • Standard topical antibiotics are appropriate for most pediatric cases
  • Systemic therapy with oral erythromycin (50 mg/kg/day divided into four doses) for 14 days may be necessary in certain cases 1

Severe or Specific Infections

  • For gonorrheal conjunctivitis: Combination therapy with systemic ceftriaxone (25-50 mg/kg IV or IM, single dose, not to exceed 125 mg) plus topical antibiotic therapy 1
  • For chlamydial conjunctivitis: Systemic treatment in addition to topical therapy 4
  • For contact lens wearers with purulent conjunctivitis: Topical and systemic broad-spectrum antibiotics 2

When to Consider Delayed Antibiotic Treatment

Delayed antibiotic prescribing has been found to have similar symptom control as immediate prescribing 5. This approach may be considered for mild cases since:

  • 41% of patients with bacterial conjunctivitis are cured by days 6-10 without antibiotics 2
  • Uncomplicated cases often resolve in 1-2 weeks without treatment 4

Prevention and Hygiene Measures

  • Frequent handwashing
  • Avoiding sharing towels and pillowcases
  • Changing pillowcases frequently during infection
  • Avoiding touching or rubbing eyes
  • Appropriate lens care for contact lens wearers 1

When to Refer to Ophthalmology

Immediate referral is indicated for:

  • Conjunctivitis in a neonate
  • Severe pain
  • Decreased vision
  • Recent ocular surgery
  • Vesicular rash on the eyelids or nose
  • History of rheumatologic disease
  • Immunocompromised state
  • Lack of response to therapy after 3-4 days 1, 5

Common Pitfalls to Avoid

  • Overuse of antibiotics for viral conjunctivitis
  • Prolonged use of corticosteroids without ophthalmology supervision
  • Failure to recognize potentially serious causes of conjunctivitis
  • Inadequate hygiene education
  • Delayed referral for severe or non-responsive cases 1

Patients with bacterial conjunctivitis can typically return to work or school after 24 hours of antibiotic treatment 1.

References

Guideline

Ocular Infections and Inflammations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.